George Tziras
Director Ejecutivo en SMALL PHARMA INC. .
Fortuna: 447 982 $ al 30/04/2024
Perfil
George Tziras is currently the Chief Executive Officer & Director at Small Pharma, Inc. He is also a Non-Executive Director at Small Pharma Ltd.
and the Director & Chief Business Officer at Cybin, Inc. Previously, he worked as the Chief Business Officer & Director at Unilock Capital Corp.
Mr. Tziras completed his undergraduate degree at the University of Oxford and his graduate degree at The Paul H.
Nitze School of Advanced International Studies.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
CYBIN, INC.
0.17% | 05/04/2024 | 1 294 747 ( 0.17% ) | 447 982 $ | 30/04/2024 |
Cargos activos de George Tziras
| Empresas | Cargo | Inicio |
|---|---|---|
| SMALL PHARMA INC. | Director Ejecutivo | 20/07/2022 |
| CYBIN INC. | Director/Miembro de la Junta | 23/10/2023 |
Small Pharma Ltd.
 Small Pharma Ltd. Pharmaceuticals: MajorHealth Technology Small Pharma Ltd. operates as a pharmaceutical company that develops a rapid-acting antidepressant to treat patients with depression. The company was founded by Peter Rands in 2015 and is headquartered in London, the United Kingdom. | Director/Miembro de la Junta | 01/01/2015 |
Antiguos cargos conocidos de George Tziras.
| Empresas | Cargo | Fin |
|---|---|---|
| SMALL PHARMA INC. | Director/Miembro de la Junta | - |
Formación de George Tziras.
| University of Oxford | Undergraduate Degree |
| The Paul H. Nitze School of Advanced International Studies | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| SMALL PHARMA INC. | Retail Trade |
| CYBIN INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Small Pharma Ltd.
Small Pharma Ltd. Pharmaceuticals: MajorHealth Technology Small Pharma Ltd. operates as a pharmaceutical company that develops a rapid-acting antidepressant to treat patients with depression. The company was founded by Peter Rands in 2015 and is headquartered in London, the United Kingdom. | Health Technology |
Unilock Capital Corp.
 Unilock Capital Corp. Financial ConglomeratesFinance Unilock Capital Corp. is a development stage company, which engages in the identification and evaluation of assets or businesses with a view to completing a qualifying transaction. It intends to become a capital pool industry. The company was founded on January 23, 2018 and is headquartered in Vancouver, Canada. | Finance |
- Bolsa de valores
- Insiders
- George Tziras
